Rt-Qpcr Assay For Mrna Transcript Immune Biomarkers
FDA product code PRE · 4 cleared devices
Class 2
Microbiology
- Regulation
- 21 CFR 866.3215
- Review panel
- MI
- Implant
- No
- Life sustaining
- No
- Third party review
- No
- GMP exempt
- No
- Clearance span
- 2017-02-17 – 2025-01-10
A quantitative gene expression assay using reverse transcription polymerase chain reaction to quantify the relative expression levels of host response genes isolated from whole blood.
PRE
2025-01-10
PRE
2023-12-15
SeptiCyte RAPID
View details →
PRE
2021-11-29
SeptiCyte RAPID
View details →
PRE
2017-02-17
SeptiCyte LAB
View details →No matching devices.
Advertisement